Citations (74)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Mitch Earleywine, Fiona Low, Brianna R. Altman & Joseph De Leo. (2023) How Important Is a Guide Who Has Taken Psilocybin in Psilocybin-Assisted Therapy for Depression?. Journal of Psychoactive Drugs 55:1, pages 51-61.
Read now
Read now
Javier Collado-Ruano & Joselin Segovia Sarmiento. (2022) Ecological Economics Foundations to Improve Environmental Education Practices: Designing Regenerative Cultures*. World Futures 78:7, pages 456-483.
Read now
Read now
Sascha B. Thal, Liam B. Engel & Stephen J. Bright. (2022) Sober sitter or coconsumer? Psychedelics, online forums and preferences for interpersonal interactions. Addiction Research & Theory 30:5, pages 382-390.
Read now
Read now
Maha N. Mian, B. R. Altman & M. Earleywine. (2020) Ayahuasca’s Antidepressant Effects Covary with Behavioral Activation as Well as Mindfulness. Journal of Psychoactive Drugs 52:2, pages 130-137.
Read now
Read now
Andrew Kristoffer Dean. (2019) The enchanted snake and the forbidden fruit: the ayahuasca ‘fairy tale’ tourist. Journal of Marketing Management 35:9-10, pages 818-844.
Read now
Read now
Albert Garcia-Romeu & William A. Richards. (2018) Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions. International Review of Psychiatry 30:4, pages 291-316.
Read now
Read now
Peter S. Hendricks. (2018) Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy. International Review of Psychiatry 30:4, pages 331-342.
Read now
Read now
Petr Winkler & Ladislav Csémy. (2014) Self-Experimentations with Psychedelics Among Mental Health Professionals: LSD in the Former Czechoslovakia. Journal of Psychoactive Drugs 46:1, pages 11-19.
Read now
Read now
Anette Kjellgren & Kristoffer Jonsson. (2013) Methoxetamine (MXE) – A Phenomenological Study of Experiences Induced by a “Legal High” from the Internet. Journal of Psychoactive Drugs 45:3, pages 276-286.
Read now
Read now
Anette Kjellgren & Christophe Soussan. (2011) Heaven and Hell—A Phenomenological Study of Recreational Use of 4-HO-MET in Sweden. Journal of Psychoactive Drugs 43:3, pages 211-219.
Read now
Read now
Arthur Saniotis. (2010) Evolutionary and Anthropological Approaches Towards Understanding Human Need for Psychotropic and Mood Altering Substances. Journal of Psychoactive Drugs 42:4, pages 477-484.
Read now
Read now
Eliana Rodrigues & E.A. Carlini. (2006) A Comparison of Plants Utilized in Ritual Healing by Two Brazilian Cultures: Quilombolas and Krahô Indians. Journal of Psychoactive Drugs 38:3, pages 285-295.
Read now
Read now
JamesB. Hittner & SusanB. Quello. (2004) Combating Substance Abuse with Ibogaine: Pre- and Posttreatment Recommendations and an Example of Successive Model Fitting Analyses. Journal of Psychoactive Drugs 36:2, pages 191-199.
Read now
Read now
Articles from other publishers (61)
Mitch Earleywine & Samantha G. Gomez. (2024) Is Personal Experience Essential for Effective Psychedelic Therapists?: The Challenges of Small, Accumulating Therapist Effects. Psychedelic Medicine.
Crossref
Crossref
Sepehr Mortaheb, Larry D. Fort, Natasha L. Mason, Pablo Mallaroni, Johannes G. Ramaekers & Athena Demertzi. (2024) Dynamic Functional Hyperconnectivity after Psilocybin Intake is Primarily Associated with Oceanic Boundlessness. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
Crossref
Crossref
Atheer Ganem, P. Emile Rossouw, Dimitrios Michelogiannakis & Fawad Javed. (2023) Antinociceptive Efficacy of Shamanic Healing for the Management of Temporomandibular Disorders: An Evidence-Based Review. Journal of Religion and Health 63:2, pages 942-953.
Crossref
Crossref
Buyandelger Batmunkh & Munguntuul Enkhbat. (2023) Mongolian philosophical underpinnings of well‐being: Mythology, shamanism and Mongolian Buddhism (before the development of modern nursing). Nursing Philosophy 25:1.
Crossref
Crossref
Marjolein Doesburg-van Kleffens, Amy M. Zimmermann-Klemd & Carsten Gründemann. (2023) An Overview on the Hallucinogenic Peyote and Its Alkaloid Mescaline: The Importance of Context, Ceremony and Culture. Molecules 28:24, pages 7942.
Crossref
Crossref
Farida Larit & Francisco León. (2023) Therapeutics to Treat Psychiatric and Neurological Disorders: A Promising Perspective from Algerian Traditional Medicine. Plants 12:22, pages 3860.
Crossref
Crossref
Brad Stoddard. (2023) Entheogens: Psychedelic religion in the United States, part two. Religion Compass 17:11.
Crossref
Crossref
Nuno Azevedo, Miguel Oliveira Da Silva & Luís Madeira. (2023) Ethics of Psychedelic Use in Psychiatry and Beyond—Drawing upon Legal, Social and Clinical Challenges. Philosophies 8:5, pages 76.
Crossref
Crossref
José Carlos Bouso, Genís Ona, Maja Kohek, Rafael G. dos Santos, Jaime E. C. Hallak, Miguel Ángel Alcázar-Córcoles & Joan Obiols-Llandrich. (2023) Hallucinations and Hallucinogens: Psychopathology or Wisdom?. Culture, Medicine, and Psychiatry 47:2, pages 576-604.
Crossref
Crossref
S. B. Thal, M. Wieberneit, J. M. Sharbanee, P. M. Skeffington, R. Bruno, T. Wenge & S. J. Bright. (2023) Dosing and Therapeutic Conduct in Administration Sessions in Substance-Assisted Psychotherapy: A Systematized Review. Journal of Humanistic Psychology.
Crossref
Crossref
Juliet Meccia, Joëlle Lopez & Rosemary C. Bagot. (2022) Probing the antidepressant potential of psilocybin: integrating insight from human research and animal models towards an understanding of neural circuit mechanisms. Psychopharmacology 240:1, pages 27-40.
Crossref
Crossref
Caroline L. Alves, Rubens Gisbert Cury, Kirstin Roster, Aruane M. Pineda, Francisco A. Rodrigues, Christiane Thielemann & Manuel Ciba. (2022) Application of machine learning and complex network measures to an EEG dataset from ayahuasca experiments. PLOS ONE 17:12, pages e0277257.
Crossref
Crossref
Sascha B Thal, Michelle Wieberneit, Jason M Sharbanee, Petra M Skeffington, Paris Baker, Raimondo Bruno, Tobias Wenge & Stephen J Bright. (2022) Therapeutic (Sub)stance: Current practice and therapeutic conduct in preparatory sessions in substance-assisted psychotherapy—A systematized review. Journal of Psychopharmacology 36:11, pages 1191-1207.
Crossref
Crossref
Marija Franka Žuljević, Ivan Buljan, Mia Leskur, Mariano Kaliterna, Darko Hren & Darko Duplančić. (2022) Validation of a new instrument for assessing attitudes on psychedelics in the general population. Scientific Reports 12:1.
Crossref
Crossref
Gabriella Gobbi, Antonio Inserra, Kyle T. Greenway, Michael Lifshitz & Laurence J. Kirmayer. (2022) Psychedelic medicine at a crossroads: Advancing an integrative approach to research and practice. Transcultural Psychiatry 59:5, pages 718-724.
Crossref
Crossref
Nataliya Vorobyeva & Alena A. Kozlova. (2022) Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders. Frontiers in Pharmacology 13.
Crossref
Crossref
Sam Gandy. (2022) Predictors and potentiators of psychedelic-occasioned mystical experiences. Journal of Psychedelic Studies 6:1, pages 31-47.
Crossref
Crossref
Rashmi Saxena Pal, Yogendra Pal, Deepti Katiyar, Kanav Khera & Saranya Punniyakotti. (2022) Herbal Drug Addiction: Latest Information on Trends and Outlines. Pharmacophore 13:3, pages 86-90.
Crossref
Crossref
Sascha B. Thal, Stephen J. Bright, Jason M. Sharbanee, Tobias Wenge & Petra M. Skeffington. (2021) Current Perspective on the Therapeutic Preset for Substance-Assisted Psychotherapy. Frontiers in Psychology 12.
Crossref
Crossref
Isabel Wießner, Marcelo Falchi, Fernanda Palhano-Fontes, Amanda Feilding, Sidarta Ribeiro & Luís Fernando Tófoli. (2021) LSD, madness and healing: Mystical experiences as possible link between psychosis model and therapy model. Psychological Medicine, pages 1-15.
Crossref
Crossref
Michael James Winkelman. (2021) The Evolved Psychology of Psychedelic Set and Setting: Inferences Regarding the Roles of Shamanism and Entheogenic Ecopsychology. Frontiers in Pharmacology 12.
Crossref
Crossref
Anna Lutkajtis. (2021) Entity encounters and the therapeutic effect of the psychedelic mystical experience. Journal of Psychedelic Studies 4:3, pages 171-178.
Crossref
Crossref
Janis Phelps & James Henry. 2022. Disruptive Psychopharmacology. Disruptive Psychopharmacology
93
109
.
Monnica T. Williams, Traleena M. Rouleau, Joseph T. La Torre & Noor Sharif. (2020) Cultural competency in the treatment of obsessive-compulsive disorder: practitioner guidelines. The Cognitive Behaviour Therapist 13.
Crossref
Crossref
Ansgar Rougemont-Bücking. 2020. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen
1
16
.
Jonathan Hamill, Jaime Hallak, Serdar M. Dursun & Glen Baker. (2019) Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness. Current Neuropharmacology 17:2, pages 108-128.
Crossref
Crossref
Edward James, Thomas L Robertshaw, Michael J Pascoe, Fiona M Chapman, Andrew D Westwell & Andrew P Smith. (2019) Using the pharmacy retail model to examine perceptions and biases of a UK population sample towards regulation of specific psychoactive drugs. Drug Science, Policy and Law 5, pages 205032451987612.
Crossref
Crossref
Elizabeth M. Nielson & Jeffrey Guss. (2018) The influence of therapists’ first-hand experience with psychedelics on psychedelic-assisted psychotherapy research and therapist training. Journal of Psychedelic Studies 2:2, pages 64-73.
Crossref
Crossref
Cassandra Vieten, Helané Wahbeh, B. Rael Cahn, Katherine MacLean, Mica Estrada, Paul Mills, Michael Murphy, Shauna Shapiro, Dean Radin, Zoran Josipovic, David E. Presti, Michael Sapiro, Jan Chozen Bays, Peter Russell, David Vago, Fred Travis, Roger Walsh & Arnaud Delorme. (2018) Future directions in meditation research: Recommendations for expanding the field of contemplative science. PLOS ONE 13:11, pages e0205740.
Crossref
Crossref
Sean J. Belouin & Jack E. Henningfield. (2018) Psychedelics: Where we are now, why we got here, what we must do. Neuropharmacology 142, pages 7-19.
Crossref
Crossref
Robin Rodd. (2018) It’s all you! Australian ayahuasca drinking, spiritual development, and immunitary individualism. Critique of Anthropology 38:3, pages 325-345.
Crossref
Crossref
Laura Orsolini, Michela Ciccarese, Duccio Papanti, Domenico De Berardis, Amira Guirguis, John M. Corkery & Fabrizio Schifano. (2018) Psychedelic Fauna for Psychonaut Hunters: A Mini-Review. Frontiers in Psychiatry 9.
Crossref
Crossref
Christian Sueur. (2018) État des lieux de la recherche sur les capacités thérapeutiques des « substances hallucinogènes » au 21 e siècle. Psychotropes Vol. 23:3, pages 125-163.
Crossref
Crossref
Camila Sanz, Federico Zamberlan, Earth Erowid, Fire Erowid & Enzo Tagliazucchi. (2018) The Experience Elicited by Hallucinogens Presents the Highest Similarity to Dreaming within a Large Database of Psychoactive Substance Reports. Frontiers in Neuroscience 12.
Crossref
Crossref
Torsten Passie. (2018) The early use of MDMA (‘Ecstasy’) in psychotherapy (1977–1985). Drug Science, Policy and Law 4, pages 205032451876744.
Crossref
Crossref
Ansgar Rougemont-Bücking. 2018. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen
437
451
.
M. E. Endress, U. Meve, D. J. Middleton & S. Liede-Schumann. 2018. Flowering Plants. Eudicots. Flowering Plants. Eudicots
207
411
.
Janis Phelps. (2017) Developing Guidelines and Competencies for the Training of Psychedelic Therapists. Journal of Humanistic Psychology 57:5, pages 450-487.
Crossref
Crossref
Zurina Hassan, Oliver G. Bosch, Darshan Singh, Suresh Narayanan, B. Vicknasingam Kasinather, Erich Seifritz, Johannes Kornhuber, Boris B. Quednow & Christian P. Müller. (2017) Novel Psychoactive Substances—Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs. Frontiers in Psychiatry 8.
Crossref
Crossref
Eliana L. Sánchez-Montoya, Marco A. Reyes, Joel Pardo, Juana Nuñez-Alarcón, José G. Ortiz, Juan C. Jorge, Jorge Bórquez, Andrei Mocan & Mario J. Simirgiotis. (2017) High Resolution UHPLC-MS Metabolomics and Sedative-Anxiolytic Effects of Latua pubiflora: A Mystic Plant used by Mapuche Amerindians. Frontiers in Pharmacology 8.
Crossref
Crossref
Enzo Tagliazucchi, Leor Roseman, Mendel Kaelen, Csaba Orban, Suresh D. Muthukumaraswamy, Kevin Murphy, Helmut Laufs, Robert Leech, John McGonigle, Nicolas Crossley, Edward Bullmore, Tim Williams, Mark Bolstridge, Amanda Feilding, David J. Nutt & Robin Carhart-Harris. (2016) Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution. Current Biology 26:8, pages 1043-1050.
Crossref
Crossref
Ede Frecska, Petra Bokor & Michael Winkelman. (2016) The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization. Frontiers in Pharmacology 7.
Crossref
Crossref
Ansgar Rougemont-Bücking. 2016. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen
1
19
.
Eduardo Ekman Schenberg, João Felipe Morel Alexandre, Renato Filev, Andre Mascioli Cravo, João Ricardo Sato, Suresh D. Muthukumaraswamy, Maurício Yonamine, Marian Waguespack, Izabela Lomnicka, Steven A. Barker & Dartiu Xavier da Silveira. (2015) Acute Biphasic Effects of Ayahuasca. PLOS ONE 10:9, pages e0137202.
Crossref
Crossref
Ana Margarida Araújo, Félix Carvalho, Maria de Lourdes Bastos, Paula Guedes de Pinho & Márcia Carvalho. (2015) The hallucinogenic world of tryptamines: an updated review. Archives of Toxicology 89:8, pages 1151-1173.
Crossref
Crossref
Tomislav Majić, Timo T Schmidt & Jürgen Gallinat. (2015) Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences?. Journal of Psychopharmacology 29:3, pages 241-253.
Crossref
Crossref
Washington Soares Ferreira Júnior, Margarita Paloma Cruz, Fábio José Vieira & Ulysses Paulino Albuquerque. 2015. Evolutionary Ethnobiology. Evolutionary Ethnobiology
185
197
.
Christophe Soussan & Anette Kjellgren. (2017) The Flip Side of “Spice”: The Adverse Effects of Synthetic Cannabinoids as Discussed on a Swedish Internet Forum. Nordic Studies on Alcohol and Drugs 31:2, pages 207-220.
Crossref
Crossref
Alain Gaujac, Sabrina Teixeira Martinez, Arão Araújo Gomes, Sandro José de Andrade, Angelo da Cunha Pinto, Jorge Maurício David, Sandro Navickiene & Jailson Bittencourt de Andrade. (2013) Application of analytical methods for the structural characterization and purity assessment of N,N-dimethyltryptamine, a potent psychedelic agent isolated from Mimosa tenuiflora inner barks. Microchemical Journal 109, pages 78-83.
Crossref
Crossref
Anette KjellgrenHelena HenningssonChristophe Soussan. (2013) Fascination and Social Togetherness–-Discussions about Spice Smoking on a Swedish Internet Forum. Substance Abuse: Research and Treatment 7, pages SART.S13323.
Crossref
Crossref
Daniel I. Brierley & Colin Davidson. (2012) Developments in harmine pharmacology — Implications for ayahuasca use and drug-dependence treatment. Progress in Neuro-Psychopharmacology and Biological Psychiatry 39:2, pages 263-272.
Crossref
Crossref
Michael P. Bogenschutz & Jessica M. Pommy. (2012) Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses. Drug Testing and Analysis 4:7-8, pages 543-555.
Crossref
Crossref
Alain Gaujac, Sandro Navickiene, Mark I. Collins, Simon D. Brandt & Jailson Bittencourt de Andrade. (2012) Analytical techniques for the determination of tryptamines and β‐carbolines in plant matrices and in psychoactive beverages consumed during religious ceremonies and neo‐shamanic urban practices. Drug Testing and Analysis 4:7-8, pages 636-648.
Crossref
Crossref
Christopher T. Burris & Eugene Lai. (2012) Through with the looking glass: Escape responses to implicit mirror exposure. Consciousness and Cognition 21:1, pages 464-470.
Crossref
Crossref
Gil Raz. (2012) Imbibing the Universe: Methods of Ingesting the Five Sprouts1. Asian Medicine 7:1, pages 65-100.
Crossref
Crossref
Richard N. Rosenthal & Laurence M. Westreich. 2010. Clinical Addiction Psychiatry. Clinical Addiction Psychiatry
72
87
.
Katherine R. Bonson. 2005. Van Nostrand's Scientific Encyclopedia. Van Nostrand's Scientific Encyclopedia.
A. C. Parrott. (2007) The psychotherapeutic potential of MDMA (3,4-methylenedioxymethamphetamine): an evidence-based review. Psychopharmacology 191:2, pages 181-193.
Crossref
Crossref
Madonna G. Constantine, Linda James Myers, Mai Kindaichi & James L. MooreIIIIII. (2011) Exploring Indigenous Mental Health Practices: The Roles of Healers and Helpers in Promoting Well‐Being in People of Color. Counseling and Values 48:2, pages 110-125.
Crossref
Crossref
Michael Winkelman. (2016) Psychointegrators: Multidisciplinary Perspectives on the Therapeutic Effects of Hallucinogens. Complementary health practice review 6:3, pages 219-237.
Crossref
Crossref
Katherine R Bonson. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences.